Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Elleri

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Pediatric Diabetes|December 6, 2003
The severity of clinical presentation of type 1 diabetes in children does not significantly influence the pattern of residual beta-cell function and long-term metabolic controlSilvana Salardi, Stefano Zucchini, Alessandro Cicognani, et al.
Pediatric Diabetes|May 30, 2008
Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnairesLaura Nardi, Stefano Zucchini, Franco D'Alberton, et al.
Diabetologia|December 25, 2014
Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trialYue Ruan, Daniela Elleri, Janet M Allen, et al.
Parasitology International|July 7, 2007
A case of furuncular myiasis associated with systemic inflammationStefania Varani, Davide Tassinari, Daniela Elleri, et al.
Diabetes Care|January 30, 2004
High glucose levels induce an increase in membrane antioxidants, in terms of vitamin E and coenzyme Q10, in children and adolescents with type 1 diabetesSilvana Salardi, Stefano Zucchini, Daniela Elleri, et al.
Diabetes Research and Clinical Practice|August 1, 2009
Effect of delay on measurement of blood glucose levels in young subjects with type 1 diabetesDaniela Elleri, Carlo L Acerini, Janet M Allen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|November 19, 2016
Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADHRuben H Willemsen, Violeta Delgado-Carballar, Daniela Elleri, et al.
BMJ Open Diabetes Research & Care|December 17, 2014
Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strengthDaniela Elleri, Janet M Allen, Martin Tauschmann, et al.
Diabetes Technology & Therapeutics|January 20, 2010
Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetesDaniela Elleri, Carlo L Acerini, Janet M Allen, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studiesMalgorzata E Wilinska, Erwin S Budiman, Marc B Taub, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Pediatric Diabetes|December 6, 2003
The severity of clinical presentation of type 1 diabetes in children does not significantly influence the pattern of residual beta-cell function and long-term metabolic controlSilvana Salardi, Stefano Zucchini, Alessandro Cicognani, et al.
Pediatric Diabetes|May 30, 2008
Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnairesLaura Nardi, Stefano Zucchini, Franco D'Alberton, et al.
Diabetologia|December 25, 2014
Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trialYue Ruan, Daniela Elleri, Janet M Allen, et al.
Parasitology International|July 7, 2007
A case of furuncular myiasis associated with systemic inflammationStefania Varani, Davide Tassinari, Daniela Elleri, et al.
Diabetes Care|January 30, 2004
High glucose levels induce an increase in membrane antioxidants, in terms of vitamin E and coenzyme Q10, in children and adolescents with type 1 diabetesSilvana Salardi, Stefano Zucchini, Daniela Elleri, et al.
Diabetes Research and Clinical Practice|August 1, 2009
Effect of delay on measurement of blood glucose levels in young subjects with type 1 diabetesDaniela Elleri, Carlo L Acerini, Janet M Allen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|November 19, 2016
Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADHRuben H Willemsen, Violeta Delgado-Carballar, Daniela Elleri, et al.
BMJ Open Diabetes Research & Care|December 17, 2014
Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strengthDaniela Elleri, Janet M Allen, Martin Tauschmann, et al.
Diabetes Technology & Therapeutics|January 20, 2010
Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetesDaniela Elleri, Carlo L Acerini, Janet M Allen, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studiesMalgorzata E Wilinska, Erwin S Budiman, Marc B Taub, et al.
Pageof 6